TY - JOUR
T1 - T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis
AU - Sawai, Hirokazu
AU - Park, Yong Wook
AU - Roberson, James
AU - Imai, Toshio
AU - Goronzy, Jörg J.
AU - Weyand, Cornelia M.
PY - 2005/5
Y1 - 2005/5
N2 - Objective. Patients with rheumatoid arthritis (RA) accumulate prematurely aged T cells that have acquired a new profile of regulatory receptors. Many of the de novo-expressed receptors are typically found on natural killer cells, including CX3CR1, the receptor for the chemokine fractalkine (FKN). This study explored whether interactions between CX3CR1 and FKN are relevant for T cell functions in rheumatoid synovitis. Methods. FKN expression was examined by real-time polymerase chain reaction and immunohistochemistry. CX3CR1 expression on peripheral blood T cells was analyzed by flow cytometry. T cell activation was quantified by determining proliferative responses, interferon-γ (IFNγ) secretion, and granule release. Fibroblast-like synoviocyte (FLS)/T cell adhesion was measured by the retention of 5-carboxyfluorescein diacetate succinimidyl ester-labeled T cells on FLS monolayers. Results. FKN was expressed on cultured synovial fibroblasts and hyperplastic synoviocytes in the rheumatoid tissue. Among CD4+ T cells, only senescent CD28- T cells were positive for CX3CR1 (P < 0.001). Such CD4+,CD28-,CX3CR1+ T cells strongly adhered to FLS, with soluble FKN blocking the interaction. FKN expressed on FLS costimulated T cell-activating signals and amplified proliferation, IFNγ production, and expulsion of cytoplasmic granules. Conclusion. Senescent CD4+ T cells that accumulate in rheumatoid arthritis aberrantly express CX3CR1. FKN, which is membrane-anchored on synoviocytes, enhances CD4+ T cell adhesion, provides survival signals, and costimulates the production of proinflammatory cytokines as well as the release of granules. By virtue of their altered receptor profile, senescent CD4+ T cells receive strong stimulatory signals from nonprofessional antigen-presenting cells in the synovial microenvironment.
AB - Objective. Patients with rheumatoid arthritis (RA) accumulate prematurely aged T cells that have acquired a new profile of regulatory receptors. Many of the de novo-expressed receptors are typically found on natural killer cells, including CX3CR1, the receptor for the chemokine fractalkine (FKN). This study explored whether interactions between CX3CR1 and FKN are relevant for T cell functions in rheumatoid synovitis. Methods. FKN expression was examined by real-time polymerase chain reaction and immunohistochemistry. CX3CR1 expression on peripheral blood T cells was analyzed by flow cytometry. T cell activation was quantified by determining proliferative responses, interferon-γ (IFNγ) secretion, and granule release. Fibroblast-like synoviocyte (FLS)/T cell adhesion was measured by the retention of 5-carboxyfluorescein diacetate succinimidyl ester-labeled T cells on FLS monolayers. Results. FKN was expressed on cultured synovial fibroblasts and hyperplastic synoviocytes in the rheumatoid tissue. Among CD4+ T cells, only senescent CD28- T cells were positive for CX3CR1 (P < 0.001). Such CD4+,CD28-,CX3CR1+ T cells strongly adhered to FLS, with soluble FKN blocking the interaction. FKN expressed on FLS costimulated T cell-activating signals and amplified proliferation, IFNγ production, and expulsion of cytoplasmic granules. Conclusion. Senescent CD4+ T cells that accumulate in rheumatoid arthritis aberrantly express CX3CR1. FKN, which is membrane-anchored on synoviocytes, enhances CD4+ T cell adhesion, provides survival signals, and costimulates the production of proinflammatory cytokines as well as the release of granules. By virtue of their altered receptor profile, senescent CD4+ T cells receive strong stimulatory signals from nonprofessional antigen-presenting cells in the synovial microenvironment.
UR - http://www.scopus.com/inward/record.url?scp=18644371735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18644371735&partnerID=8YFLogxK
U2 - 10.1002/art.21140
DO - 10.1002/art.21140
M3 - Article
C2 - 15880821
AN - SCOPUS:18644371735
SN - 0004-3591
VL - 52
SP - 1392
EP - 1401
JO - Arthritis and rheumatism
JF - Arthritis and rheumatism
IS - 5
ER -